{
    "title": "Individual feed for https://stocktwits.com/sitemap/rss_feed.xml",
    "link": "https://stocktwits.com/sitemap/rss_feed.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-23T11:02:47.267343",
    "items": [
        {
            "title": "Why Did MAAS Stock Gain Over 9% Today?",
            "link": "https://stocktwits.com/news-articles/markets/equity/why-did-maas-stock-gain-today/cmyRJjbR4g8",
            "description": "Maase will pay roughly RMB1.1 billion ($157 million) to secure 100% of Times Good’s equity, which controls the Huazhi Group.",
            "pubDate": "2026-01-23T15:52:45",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Spot Silver Touches $100 An Ounce For First Time Ever, Gold Within Striking Distance Of $5,000 Amid Lingering Geopolitical Tensions",
            "link": "https://stocktwits.com/news-articles/markets/equity/silver-price-touch-100-gold-price-within-5000/cmyRJKbR4gF",
            "description": "Silver futures maturing in March soared by nearly 4% to $100.06.",
            "pubDate": "2026-01-23T15:50:59",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png"
        },
        {
            "title": "Amaze Announces Expanded Partnership with Contend to Scale the Next Generation of Creator-Led Commerce",
            "link": "https://stocktwits.com/news-articles/business/others/amaze-announces-expanded-partnership-with-contend-to-scale-the-next-generation-of-creator-led-commerce/cmyR7o0R4gl",
            "description": "",
            "pubDate": "2026-01-23T15:20:48",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "IBRX Stock Sees Volatile Session – ImmunityBio’s Update In Phase 2 Glioblastoma Trial Sparks Buzz",
            "link": "https://stocktwits.com/news-articles/markets/equity/ibrx-stock-volatility-after-immunitybio-phase-2-glioblastoma-trial-update/cmyR7VnR4gk",
            "description": "ImmunityBio stated that it has not yet achieved median survival in patients receiving Anktiva + CAR-NK treatment in the trial.",
            "pubDate": "2026-01-23T15:18:11",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Intel Draws Mixed Street Reaction After Strong Q4 But Cautious 2026 Outlook",
            "link": "https://stocktwits.com/news-articles/markets/equity/intel-draws-mixed-street-reaction-after-strong-q4-but-cautious-2026-outlook/cmyR7jNR4gj",
            "description": "UBS raised its target to $52 from $49, with a ‘Neutral’ rating, citing supply bottlenecks and structural limitations that may constrain Intel’s AI gro...",
            "pubDate": "2026-01-23T15:14:37",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        }
    ]
}